IHM
GILD icon

Iguana Healthcare Management’s Gilead Sciences GILD Stock Holding History

Iguana Healthcare Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-30,000
Closed -$2.37M – 70
2016
Q3 		$2.37M Buy
+30,000
New +$2.44M 0.42% 64
2014
Q2 		– Sell
-15,000
Closed -$1.06M – 72
2014
Q1 		$1.06M Buy
+15,000
New +$1.18M 0.49% 54

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Iguana Healthcare Management's GILD Position: Q2 2017 in Review

Iguana Healthcare Management sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 25,000 shares — an estimated $1.7M sold.

Iguana Healthcare Management first reported a position in GILD in Q4 2013 and held it in 14 quarters. The position peaked at $12.5M in Q3 2014. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Iguana Healthcare Management reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 25,000 Gilead Sciences shares in Q2 2017, an estimated $1.7M.
  • Iguana Healthcare Management first reported a position in Gilead Sciences in Q4 2013 and held it in 14 quarters.
  • Iguana Healthcare Management's Gilead Sciences position peaked at $12.5M in Q3 2014.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.